Vigilant X4 Crt-D
Payments companies reported to CMS as associated with Vigilant X4 Crt-D. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Vigilant X4 Crt-D, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Vigilant X4 Crt-D
These are the largest totals companies reported as associated with Vigilant X4 Crt-D. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Eric Aviles | Cayey, PR | Cardiovascular Disease | $1,500.00 |
| Hector Banchs | Carolina, PR | Cardiovascular Disease | $1,350.00 |
| David Mok | Burbank, CA | Clinical Cardiac Electrophysiology | $307.11 |
| Michael Kalus | Sagamore Hills, OH | Cardiovascular Disease | $248.17 |
| Marco Mercader | Washington, DC | Clinical Cardiac Electrophysiology | $246.33 |
| Gurusher Panjrath | Washington, DC | Advanced Heart Failure and Transplant Cardiology | $246.33 |
| Vladimir Vekstein | Mayfield Hgts, OH | Cardiovascular Disease | $238.26 |
| Shivam Saxena | Bethlehem, PA | Clinical Cardiac Electrophysiology | $210.40 |
| Sharon Magoolaghan | Stow, OH | Nurse Practitioner | $193.39 |
| Khashayar Hematpour | Boston, MA | Cardiovascular Disease | $191.79 |
Prescribed Vigilant X4 Crt-D?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.